1 · At a Glance
- Treat the ECG and the clinical picture, not the lab number alone — ECG changes or haemodynamic compromise mean emergency treatment now, regardless of the exact potassium value.
- Severity (UK Kidney Association): Normal ≤5.4 · Mild 5.5–5.9 · Moderate 6.0–6.4 · Severe ≥6.5 mmol/L.
- Any K⁺ ≥6.0 mmol/L → urgent 12-lead ECG.
- ECG changes present, or K⁺ ≥6.5 mmol/L → give IV calcium immediately, start potassium-shifting therapy (insulin/glucose ± salbutamol), and arrange definitive potassium removal.
- Calcium does NOT lower potassium — it protects the heart. Insulin/glucose and salbutamol only shift potassium temporarily. Only binders, diuretics and dialysis actually remove potassium from the body.
- Related EMOnCall protocols: Acute Hypokalaemia — Adult · Acute Hypomagnesaemia — Adult
2 · Immediate Assessment
- ABCDE approach; assess for haemodynamic instability
- Continuous cardiac monitoring; obtain a 12-lead ECG urgently
- Secure IV access
- If pseudohyperkalaemia is suspected (haemolysed sample, delayed processing, difficult venepuncture, marked leucocytosis/thrombocytosis), send a repeat sample — but do NOT delay emergency treatment if there is severe hyperkalaemia or characteristic ECG changes
- Consider a venous or arterial blood gas for a rapid potassium result while formal laboratory bloods are pending
- Check blood glucose, renal function (urea, creatinine, eGFR), bicarbonate/acid–base status, and other relevant investigations (calcium, magnesium, creatine kinase if rhabdomyolysis is suspected)
3 · Severity Classification (UK Kidney Association)
- Normal: K⁺ ≤5.4 mmol/L
- Mild: K⁺ 5.5–5.9 mmol/L
- Moderate: K⁺ 6.0–6.4 mmol/L
- Severe: K⁺ ≥6.5 mmol/L
- Treatment decisions depend on more than the number alone — always weigh ECG findings, symptoms, rate of rise (a rise of >0.5 mmol/L in under 12 hours is considered acute/significant), renal function, overall clinical condition, and the underlying cause
- Local variation: some individual trust protocols use a different continuous-cardiac-monitoring trigger (e.g. ≥7.0 mmol/L) or slightly different action thresholds than the national UKKA bands above — always check local policy alongside this protocol
4 · ECG Features of Hyperkalaemia
- Tall, peaked T waves (usually the earliest change)
- PR interval prolongation
- Flattened or absent P waves
- Widening QRS complex
- Bradycardia
- AV block
- Ventricular arrhythmias
- Sine-wave pattern
- Cardiac arrest (asystole, pulseless electrical activity, or ventricular fibrillation)
- A normal ECG does NOT exclude dangerous hyperkalaemia — act on the potassium level, clinical context and rate of rise even when the ECG looks reassuring
5 · IV Calcium — Protect the Heart
- Calcium does NOT lower serum potassium — it stabilises the cardiac cell membrane and reduces the risk of life-threatening arrhythmia; always give it alongside, not instead of, potassium-shifting/removal treatment
- Indication: any ECG changes of hyperkalaemia, or severe hyperkalaemia (K⁺ ≥6.5 mmol/L) even before ECG changes appear
- Calcium gluconate 10% (preferred outside cardiac arrest): 30 mL of 10% calcium gluconate IV over 10 minutes via a secure, free-flowing peripheral line — less irritant to tissue than calcium chloride if extravasation occurs
- Calcium chloride 10% (cardiac arrest / peri-arrest only): 10 mL of 10% calcium chloride IV over 5 minutes — contains roughly three times more elemental calcium per mL than the gluconate salt, but is significantly more irritant; give via the largest available vein, ideally a central line, and flush well
- Onset and repeat dosing: effect begins within minutes and lasts 30–60 minutes; repeat the ECG after the first dose and repeat the calcium dose if ECG changes persist or recur
- IV access/extravasation: confirm free flow before injecting and use the most secure cannula available; monitor the injection site closely, especially with calcium chloride, which can cause tissue necrosis if it extravasates
- Do NOT give calcium and sodium bicarbonate through the same line without flushing thoroughly between them — they precipitate together
6 · Shift Potassium Intracellularly — Insulin + Glucose
- Dose: 10 units soluble (short-acting) insulin together with 25 g glucose IV — recommended for severe hyperkalaemia (K⁺ ≥6.5 mmol/L) and suggested for moderate hyperkalaemia (K⁺ 6.0–6.4 mmol/L)
- Check blood glucose before giving. If the pre-treatment glucose is <7.0 mmol/L, follow the insulin/glucose bolus with an infusion of 10% glucose at 50 mL/hour for 5 hours (a further 25 g) to prevent delayed hypoglycaemia
- Hypoglycaemia precautions: insulin-induced hypoglycaemia is the most common serious complication of this treatment — do not omit the glucose infusion in a patient with a low baseline glucose
- Blood glucose monitoring schedule: check at 0, 30, 60, 90, 120, 180, 240, 300 and 360 minutes after the insulin/glucose dose (a 6-hour monitoring protocol)
- Potassium monitoring: effect begins within 15–30 minutes and lasts several hours; recheck serum potassium per the schedule in section 11 — insulin/glucose shifts potassium into cells temporarily, it does not remove it from the body
7 · Shift Potassium Intracellularly — Nebulised Salbutamol
- Dose: nebulised salbutamol 10–20 mg — note this is substantially higher than the standard bronchodilator dose
- Role: an adjunct only — recommended alongside insulin/glucose in severe hyperkalaemia, and may be considered as an adjunct in moderate hyperkalaemia
- Onset: effect begins within 15–30 minutes and lasts around 2 hours
- Do NOT use salbutamol as a substitute for insulin/glucose in severe hyperkalaemia — it is not effective as monotherapy
- Cautions: tachycardia and tremor are common; use with caution in significant cardiac ischaemia or tachyarrhythmia; some patients (more often those with renal failure) have a blunted response
8 · Remove Potassium From the Body
- Insulin/glucose, salbutamol and calcium are temporising measures only — none of them remove potassium from the body; definitive treatment needs one of the options below
- Sodium zirconium cyclosilicate (SZC): 10 g orally three times daily for up to 72 hours — an option for emergency management of severe hyperkalaemia, and for consideration in moderate hyperkalaemia
- Patiromer: 8.4 g orally once daily (may be titrated in 8.4 g increments, maximum 25.2 g daily) — an option for moderate or severe hyperkalaemia; not available in Scotland
- Calcium resonium (calcium polystyrene sulfonate): no longer routinely recommended for acute hyperkalaemia in the current UKKA guideline — removed from the acute treatment pathway in the 2023 update
- Loop diuretics (e.g. furosemide): may promote urinary potassium loss, but only where renal function and urine output allow — not a substitute for dialysis in significant renal impairment
- Haemodialysis / renal replacement therapy: the most effective and definitive method of potassium removal, particularly in severe AKI, established renal failure, or hyperkalaemia refractory to medical therapy
- URGENT RENAL/ICU CONSULTATION AND CONSIDERATION OF DIALYSIS if: severe hyperkalaemia not responding to treatment, significant AKI/oliguria or established renal failure, recurrent or rapidly rising potassium, or any hyperkalaemic cardiac arrest
9 · Cardiac Arrest Due to Hyperkalaemia
- Distinguish clearly: hyperkalaemia with a pulse is managed as above; hyperkalaemic cardiac arrest needs immediate ALS plus hyperkalaemia-specific treatment given in rapid succession
- Start standard ALS immediately: continuous chest compressions, early defibrillation for shockable rhythms, adrenaline and standard ALS drugs per usual protocol
- Calcium: calcium chloride 10% 10 mL IV (preferred in arrest — more elemental calcium per mL) or calcium gluconate 10% 30 mL IV if chloride is unavailable — give as an urgent IV bolus via the largest available line, flushed well
- Insulin + glucose: 10 units soluble insulin with 25 g glucose IV, given without delay
- Sodium bicarbonate: 50 mmol sodium bicarbonate IV when hyperkalaemia is known or strongly suspected to be the cause of the arrest — give through a separate line, or flush thoroughly between this and calcium, as they precipitate together if mixed
- Take a blood gas as soon as possible during the arrest to confirm potassium and guide ongoing treatment
- Refractory arrest: consider urgent extracorporeal CPR (ECPR)/dialysis in line with local protocols if initial resuscitation is unsuccessful
- Continue standard post-resuscitation care and arrange urgent renal/ICU involvement and dialysis after ROSC if potassium remains elevated
10 · Identify and Treat the Underlying Cause
- Common causes: acute kidney injury; chronic kidney disease/established renal failure; ACE inhibitors; angiotensin receptor blockers (ARBs); mineralocorticoid receptor antagonists (e.g. spironolactone); potassium-sparing diuretics; NSAIDs; trimethoprim; potassium supplements; potassium-containing IV fluids; metabolic acidosis; tissue breakdown/rhabdomyolysis; tumour lysis syndrome; haemolysis/pseudohyperkalaemia; adrenal insufficiency; uncontrolled diabetes/insulin deficiency
- Medication review: stop or withhold potentially causative medications where clinically appropriate — do not simply restart the pre-admission regimen without review
- Treat any identified precipitant directly (e.g. fluids and source control for AKI, insulin for DKA/HHS, steroids for adrenal insufficiency) alongside potassium-lowering treatment
11 · Monitoring After Treatment
- Serum potassium: recheck at a minimum of 1, 2, 4, 6 and 24 hours after treatment of moderate or severe hyperkalaemia
- Blood glucose: monitor at 0, 30, 60, 90, 120, 180, 240, 300 and 360 minutes after insulin/glucose treatment — watch for both early and delayed hypoglycaemia
- ECG / cardiac rhythm: continuous cardiac monitoring for severe hyperkalaemia (K⁺ ≥6.5 mmol/L per UKKA; some local protocols use ≥7.0 mmol/L — follow the more cautious local policy) or for any ECG changes; repeat the 12-lead ECG after calcium and again as potassium starts to fall
- Rebound hyperkalaemia: potassium can rise again as the effect of insulin/glucose and salbutamol wears off, typically within a few hours — do not de-escalate monitoring on the strength of an initial improvement alone
- Delayed hypoglycaemia: risk continues for several hours after insulin — complete the full glucose-monitoring schedule even if the patient is transferred out of the ED
12 · Disposition
- Continued ED observation: may be appropriate for mild hyperkalaemia with an identified, reversible cause and no ECG changes
- Hospital admission: generally required for moderate or severe hyperkalaemia, any ECG changes, or where the underlying cause needs inpatient management
- Monitored / telemetry bed: for ongoing cardiac monitoring after treatment of severe hyperkalaemia or any ECG changes
- ICU: for hyperkalaemic cardiac arrest, haemodynamic instability, refractory hyperkalaemia, or where dialysis/inotropic/ventilatory support is needed
- Renal consultation: for significant AKI, CKD, recurrent hyperkalaemia, or need for dialysis
- Urgent dialysis: for hyperkalaemia refractory to medical therapy, severe AKI/established renal failure, or hyperkalaemic cardiac arrest
- Disposition should always account for the underlying cause, renal function, response to treatment so far, and the risk of recurrence — not the potassium level in isolation
13 · Quick ED Algorithm
Hyperkalaemia suspected or confirmed
↓
Urgent ECG + continuous cardiac monitoring
↓
ECG changes present, or K⁺ ≥6.5 mmol/L?
↓
Yes → IV calcium (protect the heart) now
↓
Shift potassium: insulin + glucose ± nebulised salbutamol
↓
Remove potassium: SZC / patiromer / loop diuretic if appropriate / dialysis if indicated
↓
Recheck potassium + blood glucose per monitoring schedule
↓
Identify and treat the underlying cause; stop causative medications
↓
Renal/ICU/dialysis if refractory, recurrent, or cardiac arrest occurs
14 · Red Flags — Call for Senior / Renal / ICU Help Now If
- Potassium at or above the severe threshold (≥6.5 mmol/L)
- ECG changes of hyperkalaemia
- Any arrhythmia
- Haemodynamic instability
- Rapidly rising potassium
- Severe AKI or established renal failure
- Hyperkalaemia refractory to treatment
- Recurrent hyperkalaemia after apparently successful treatment
- Suspected need for emergency dialysis
- Cardiac arrest — treat as hyperkalaemic cardiac arrest (section 9)